IPAR INTERPARFUMS INC
Perfumes, Cosmetics & Other Toilet Preparations · Nasdaq · SEC CIK 822663 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY2.6%
TTM net income YoY3.4%
TTM EPS YoY3.3%
Revenue 3-yr CAGR4.9%
Net income 3-yr CAGR2.3%
Margins
Gross margin64.8%
Operating margin17.9%
Net margin11.3%
FCF margin16.2%
EBITDA margin19.5%
Returns
ROE19.5%
ROA10.8%
ROIC (approx.)19.0%
Asset turnover0.96x
Leverage & solvency
Liabilities / assets30.1%
Debt / equity0.22x
Current ratio3.33x
Interest coverage44.33x
Cash quality & payout
Operating cash flow / net income1.46x
Accruals ratio-5.0%
Payout ratio60.2%
Capex / revenue0.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $1.49B | $1.45B |
| Cost of revenue | $541.29M | $524.98M |
| Gross profit | $947.22M | $927.34M |
| SG&A expense | $676.90M | $648.54M |
| Operating income | $270.32M | $274.80M |
| Interest expense | $7.25M | $7.83M |
| Pretax income | $271.33M | $268.39M |
| Income tax | $63.19M | $64.96M |
| Net income | $168.39M | $164.36M |
| EBITDA | $295.62M | $303.15M |
| EPS (basic) | 5.25 | 5.13 |
| EPS (diluted) | 5.24 | 5.12 |
| Dividends declared per share | 3.20 | 3.00 |
| Weighted avg. shares (diluted) | 32.14M | 32.12M |
| Balance sheet | ||
| Short-term investments | $137.09M | $109.31M |
| Receivables | $320.62M | $274.70M |
| Inventory | $351.38M | $371.92M |
| Current assets | $1.03B | $926.40M |
| PP&E, net | $184.89M | $153.77M |
| Intangibles | $325.19M | $282.48M |
| Total assets | $1.59B | $1.41B |
| Current liabilities | $344.00M | $332.43M |
| Short-term debt | $54.77M | $41.61M |
| Long-term debt | $121.25M | $115.73M |
| Total debt | $176.03M | $157.34M |
| Total liabilities | $481.22M | $468.62M |
| Shareholders' equity | $880.72M | $744.87M |
| Shares outstanding | 32.07M | 32.11M |
| Cash flow statement | ||
| Operating cash flow | $214.90M | $187.64M |
| Capital expenditure | $24.41M | $4.74M |
| Free cash flow | $190.49M | $182.90M |
| Investing cash flow | -$61.15M | -$44.83M |
| Financing cash flow | -$131.25M | -$100.77M |
| Depreciation & amortization | $25.30M | $28.36M |
| Stock-based compensation | $1.57M | $2.38M |
| Dividends paid | $102.72M | $96.03M |
Free plan shows the latest 2 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.